Telix PharmaceuticalsTLX
13F holders, Q2 2025 (June 30)21holders +15
16new positions
1sold out
1famous investor
$16.10avg. 13F price*
At the end of Q2 2025, 21 institutions reported holding Telix Pharmaceuticals Ltd. (TLX) in their 13F filings, up 15 from Q1 2025. 16 opened new positions and 1 sold out. The largest holders were Pier Capital, LLC ($3.0M), Russell Investments Group, Ltd. ($975K) and FMR LLC ($681K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Telix Pharmaceuticals Ltd.
- CUSIP
- 87961M105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 16 | $6.7M |
| Exits | 1 | $451K |
All 13F filers, Q1 2025 → Q2 2025: 433,060 shares bought and 28,241 shares sold, net +404,819 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Pier Capital, LLC | 0.46% | New | 188,992 | $3.0M |
| Russell Investments Group, Ltd. | 0.00% | New | 60,301 | $975K |
| FMR LLC | 0.00% | New | 42,091 | $681K |
| Citadel Advisors | 0.00% | New | 41,328 | $668K |
| Jane Street Group, LLC | 0.00% | New | 35,103 | $564K |
| Private Advisor Group, LLC | 0.00% | Add +148.2% | 25,167 | $404K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 18,475 | $297K |
| Blair William & Co. | 0.00% | New | 13,500 | $217K |
| IHT Wealth Management, LLC | 0.01% | New | 13,240 | $213K |
| UBS Group AG | 0.00% | Add +67.7% | 6,121 | $98K |
| Morgan Stanley | 0.00% | Reduce -21.9% | 4,402 | $71K |
| Raymond James Financial Inc. | 0.00% | New | 1,200 | $19K |
| Rhumbline Advisers | 0.00% | Add +3.6% | 1,187 | $19K |
| Arax Advisory Partners | 0.00% | New | 1,030 | $17K |
| Royal Bank of Canada | 0.00% | New | 141 | $2K |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -51.1% | 67 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 45 | $723 |
| JFS Wealth Advisors, LLC | 0.00% | New | 27 | $434 |
| Principal Securities, Inc. | 0.00% | New | 21 | $337 |
| Assetmark, Inc. | 0.00% | New | 18 | $289 |
| True Wealth Design, LLC | 0.00% | New | 10 | $161 |
"% of holder's portfolio" is TLX's weight in each manager's 13F, not the share of Telix Pharmaceuticals Ltd. the manager owns.